At Oak Ridge National Laboratory, it’s all-hands-on-deck for the world-leading experts in neutron scattering as they enter the fight against COVID-19. Researchers at the lab’s Spallation Neutron Source and High Flux Isotope Reactor have a plan of attack to unleash a full barrage of neutron capabilities in an ambitious set of experiments that will provide critical pieces of information about the virus’s biological structure and how it behaves.
Tag: Vaccine
Psychology Research: Antivaxxers Actually Think Differently Than Other People
In an article published recently in the journal Vaccine, two researchers in the Texas Tech University Department of Psychological Sciences suggest some people find vaccines risky because they overestimate the likelihood of negative events, particularly those that are rare.
UTEP School of Pharmacy Developing COVID-19 Vaccine, Drug Treatments Using Supercomputing
Research is underway at The University of Texas at El Paso’s School of Pharmacy to develop vaccines and antiviral drugs to combat the novel coronavirus within 15 months to two years.
Epidemiology expert: Strive for diversity in COVID-19 vaccine/drug clinical trials
As clinical trials on potential vaccines and treatment drugs for the COVID-19 disease caused by the novel coronavirus get underway, researchers should strive for diversity in test subject selection, according to a leading expert on the topic. Marjorie A. Speers,…
A New Coronavirus Vaccine Designed to Meet a Global Demand
The fastest recipe for worldwide access to a coronavirus vaccine may be to build upon on an existing vaccine with an already established manufacturing and supply chain.
Tip Sheet: Tracking COVID-19, protein design, TB vaccines, a new brain map and more
Summaries of recent Fred Hutch research findings with links for additional background and media contacts.
UW–Madison, FluGen, Bharat Biotech to develop CoroFlu, a coronavirus vaccine
An international collaboration of virologists at the University of Wisconsin–Madison and the vaccine companies FluGen and Bharat Biotech has begun the development and testing of a unique vaccine against COVID-19 called CoroFlu.
COVID-19 Vaccine Candidate Shows Promise in First Peer-Reviewed Research
A potential COVID-19 vaccine, delivered by microscopic needles, produces antibodies specific to the virus when tested in mice. This is the first peer-reviewed paper describing a COVID-19 vaccine candidate. The next step is a human clinical trial.
COVID-19 Tip Sheet: Story Ideas from Johns Hopkins
Vaccine expert working on developing covid-19 vaccine, sees major differences between Covid-19 and SARS
Understanding How COVID-19 Affects Children Vital to Slowing Pandemic, Doctors Say
Though COVID-19 so far appears to be largely sparing children, researchers are cautioning that it is critical to understand how the virus affects kids to model the pandemic accurately, limit the disease’s spread and ensure the youngest patients get the care they need.
COVID-19 Expert Panel Live Event Series – Media Invited to Attend and Submit Questions, 2 PM EDT Thursday March 12 and 2 PM EDT Monday March 16
redirect to event registration Newswise Live Expert Panel discussion of unique angles to the COVID-19 outbreak of interest to the public and the media, including public health, testing, business and financial markets, 2020 elections, and more. Experts from institutions…
Russian biologist explains recent findings regarding coronavirus structure
MOSCOW (MIPT) — The atomic structure of the novel coronavirus envelope has explained why it is exceptionally contagious. Its structural features make it much easier for the Chinese coronavirus to bind to target receptors, compared with the previously known SARS…
Using Social Media to Understand the Vaccine Debate in China
THE SITUATIONVaccine acceptance is a crucial public health issue, which has been exacerbated by the use of social media to spread content expressing vaccine hesitancy. Studies have shown that social media can provide new information regarding the dynamics of vaccine…
Exposing a virus’s hiding place reveals new potential vaccine
By figuring out how a common virus hides from the immune system, scientists have identified a potential vaccine to prevent sometimes deadly respiratory infections in humans.
Wistar Joins Global Effort to Expedite Coronavirus Vaccine Development for Outbreak Originating in China
Wistar announces today that they are part of a team to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV) that has infected hundreds in China and other countries, including the U.S., and resulted in numerous deaths to date. Wistar is part of a collaboration funded by the Coalition for Epidemic Preparedness Innovations (CEPI).
Study results will inform immunization programs globally
The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine.
Rutgers Expert Available to Discuss Ethics of NJ Vaccine Bill
T. Patrick Hill, a Rutgers-New Brunswick professor of ethics and law, is available to discuss a New Jersey bill that would eliminate religion as a reason not to vaccinate public schoolchildren. Lawmakers are expected to vote Monday afternoon. “The vaccination…
Virus surfaces help MTU engineers study vaccine and gene therapy applications
An isoelectric point is a common way to characterize viruses. However, it’s not easy. To improve manufacturing for vaccines and gene therapy, a Michigan Tech team uses surface charge to determine the isoelectric point of different viruses. Specifically, they use a single-particle method with atomic force microscopy (AFM).
Weizmann Scientists Create Decoy Molecule that Neutralizes Arenaviruses
Weizmann Institute scientists created a decoy molecule that successfully recruits the immune system to fight arenaviruses. It also appears to be heat-resistant and stable, meaning it could be delivered to the remote areas where these diseases are endemic.
Researchers Identify Potential Formula for Blood Cancer Vaccine
Researchers at the Icahn School of Medicine at Mount Sinai have discovered a way to move precision immunotherapy forward by using genomics to inform immunotherapy for multiple myeloma, a blood cancer, according to a study published in Clinical Cancer Research, a journal of the American Association for Cancer Research, in December.
Natural Toxins in the Global Food Supply Continue to Threaten the Health of Underprivileged Communities
Naturally occurring chemicals in the global food supply are known to pose a burden on worldwide health. New studies have found that a certain foodborne toxin, in addition to its known health effects,, is also linked to vaccine resistance, and for the first time the global burden of disease from foodborne arsenic, lead, cadmium, and methyl mercury has been quantified.. The Society for Risk Analysis (SRA) will present new studies as part of its Global Disease Burden Caused by Foodborne Chemicals and Toxins symposium on Monday, Dec. 9 from 1:30-3:00 p.m. as part of its 2019 Annual Meeting at the Crystal Gateway Marriott in Arlington, Virginia. This symposium will provide updates to a 2015 World Health Organization (WHO) publication which analyzed the disease burdens caused by these toxins.
Peanut allergy vaccine to rewrite the immune system
Peanut allergies could become a thing of the past as breakthrough research from the University of South Australia develops a radically novel vaccination that’s poised to cure the potentially life threatening condition.
HIV: Overwhelming the enemy from the start
Virologist Eric Cohen and his team have identified a way to thwart HIV infection at its very early stages.
Dengue new vaccine performs well in large trial, but safety remains key concern
News wise on Dengue related news. An experimental dengue vaccine has shown promising early results in a large, multicountry trial, but critical questions remain about its effectiveness and safety. Still unclear, for example, is whether the vaccine—which had an efficacy…
HOW MEASLES WIPES OUT THE BODY’S IMMUNE MEMORY
Study shows measles wipes out 20 to 50 percent of antibodies against an array of viruses and bacteria, depleting a child’s previous immunity
Measles-ravaged immune system must “relearn” how to protect the body against infections
Study details mechanism and scope of this measles-induced “immune amnesia”
Findings underscore importance of measles vaccination, suggesting those infected with measles may benefit from booster shots of all previous childhood vaccines
Flu antibody protects against numerous and wide-ranging strains
A human antibody that protects mice against a wide range of lethal flu viruses could be the key to a universal vaccine and better treatments for severe flu disease, according to a new study from Washington University School of Medicine in St. Louis, Icahn School of Medicine at Mount Sinai in New York City, and Scripps Research in La Jolla, Calif.
NATIONAL INSTITUTES OF HEALTH ESTABLISHES CENTER AT LAWRENCE LIVERMORE TO DEVELOP CHLAMYDIA VACCINE
A cooperative research center that aims to develop vaccines for chlamydia has been established by the National Institutes of Health at Lawrence Livermore National Laboratory (LLNL). The center includes two University of California campuses – Irvine and Davis.
Case Western Reserve University and University Hospitals Infectious Diseases Researcher Awarded NIH Contract to Accelerate TB Vaccine Development
CWRU’s W. Henry Boom, MD, and a team of collaborators nationally received the first installment of a seven-year contract, totaling $30 million in its first year from the National Institute of Allergy and Infectious Diseases of the NIH, to establish three immunology research centers to accelerate TB vaccine development.
Vaccine to Block Digestive Hormone May Slow Growth of Pancreatic Cancer
New research suggests a vaccine that blocks a digestive hormone may slow the spread of pancreatic cancer, potentially increasing survival rates. The study, published ahead of print in the American Journal of Physiology—Gastrointestinal and Liver Physiology, was chosen as an APSselect article for October.
Teen Advocate Ethan Lindenberger Joins UnityTM Consortium to Appeal to Teens and Parents to Get Vaccinated
The Unity Consortium is thrilled to welcome newest member, Ethan Lindenberger, a 19-year old American activist known for his opposition to vaccine misinformation efforts.
Flu Experts at Johns Hopkins Medicine
As the 2019–20 flu season gets underway, Johns Hopkins Medicine experts will be available throughout the season to talk with your newsroom about the epidemiology of this year’s virus, as well as provide important information about this year’s vaccine. Flu cases have already begun to appear in the U.S. Flu activity tends to increase in October and can run as late as May.